Delivery Order SPE2DB22D2007-SPE2DB24FJ1EM
Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564253180 STELARA 90 MG/ML syringes. The $10,146.40 contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringes. The contract, valued at $13,857.59, has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA Troop Support Medical to supply a wide...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564184918 STELARA 90 MG/ML SYRINGEML. The $35,955.07 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger $999,999,999.00 indefinite delivery contract the company holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, a $34,436.17 firm fixed price delivery order contract to provide STELARA 90 MG/ML syringes. The contract has a completion date of February 8, 2024 and was awarded on February 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $20,566.14 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML syringes. The award has a potential value of $6,715.70 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide $30,113.49 worth of STELARA 45 MG/0.5 ML syringes. The contract has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The $14,179.06 firm-fixed price contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGE. The award has a potential value of $8,081.84 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1EMDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564160144 STELARA 90 MG/ML syringes. The $13,431.40 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. No set-aside designation was used for this award.
Generated 7/3/24, 10:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 4/3/24 |